Company News

ELCYS Vial
Company News

Exela Seeks L-Cysteine Injection Patent Infringement Litigation

Lenoir, NC February 6, 2023 – Exela Pharma Sciences, LLC (“Exela”) has commenced patent infringement litigation today against Nivagen Pharmaceuticals, Inc. (“Nivagen”) in the United States District Court for the District of Delaware to prevent unauthorized launch of its recently approved 7.25% L-Cysteine injection drug product.

Exela MAX Building
Company News

PREMIER INC. + 11 Leading Health Systems Invest in Exela

CHARLOTTE, N.C., September 8, 2021 ─ Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, and 11 leading health systems acquired a minority stake in Exela Holdings, Inc., the holding company of Exela® Pharma Sciences, LLC, to secure vital supply of pharmaceutical products and support domestic production.

Featured Image for post Exela Covid-19 Response
Company News

Exela Covid-19 Response

JUNE 29, 2020 – Like many essential businesses, we at Exela have been impacted by COVID. Those who tested positive are recovering at home.

Featured image for post Exela Wins 2017 Manufacturing Leadership Award
Company News

Exela Wins 2017 Manufacturing Leadership Award

WINSTON-SALEM, NC – The North Carolina Manufacturing Extension Partnership (NCMEP), a public-private operating alliance working to help manufacturing companies become operationally efficient and well positioned to grow profitably, today announced the winners of its 2017 Manufacturing Leadership Awards at mfgCON in Winston-Salem, North Carolina.

Scroll to Top